IRadimed Corp (IRMD) income statement
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$82.31−1.14 (-1.37%)
Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –
IRadimed Corp income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 75.5%
- Operating margin
- 32.3%
- Net margin
- 26.8%
- Return on equity, FY2025
- 24.8%
Financial strength
- Current ratio
- 8.99
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 613.1%
Valuation
- P/E ratio
- 44.0
- Price to sales
- 11.78
- Price to book
- 9.89
- Dividend yield
- –
See a number that looks wrong?